Literature DB >> 16185606

Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer.

Luis Miguel Navarro Martín1, Alberto Ocaña Fernández, Cesar Augusto Rodríguez Sánchez, Isabel Ruiz Martín, Juan Jesús Cruz Hernández.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16185606     DOI： 10.1007/bf02716553

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  15 in total

1.  Tamoxifen for brain metastases from breast cancer.

Authors:  S B Hansen; H Galsgård; F E von Eyben; V Westergaard-Nielsen; J Wolf-Jensen
Journal:  Ann Neurol       Date:  1986-10       Impact factor: 10.422

2.  Brain metastases from breast cancer may respond to endocrine therapy.

Authors:  R Colomer; D Cosos; J M Del Campo; M Boada; D Rubio; L Salvador
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

3.  Central nervous system metastasis from breast carcinoma. Autopsy study.

Authors:  Y Tsukada; A Fouad; J W Pickren; W W Lane
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

4.  Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.

Authors:  W Boogerd; A A Hart; J J van der Sande; E Engelsman
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

Review 5.  Leptomeningeal metastases: a review of evaluation and treatment.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.

Authors:  Mustafa Ozdogan; Mustafa Samur; Hakan S Bozcuk; Ergin Sagtas; Mustafa Yildiz; Mehmet Artac; Burhan Savas
Journal:  Jpn J Clin Oncol       Date:  2003-05       Impact factor: 3.019

7.  Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study.

Authors:  T Siegal; U Sandbank; A Gabizon; T Siegal; R Mizrachi; E Ben-David; R Catane
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Causes of death and metastatic patterns in patients with mammary cancer. Ten-year autopsy study.

Authors:  S Y Cho; H Y Choi
Journal:  Am J Clin Pathol       Date:  1980-02       Impact factor: 2.493

9.  Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

Authors:  S A Grossman; D M Finkelstein; J C Ruckdeschel; D L Trump; T Moynihan; D S Ettinger
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

10.  The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma.

Authors:  Rose Lai; Chau T Dang; Mark G Malkin; Lauren E Abrey
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860
View more
  6 in total

Review 1.  Leptomeningeal Metastases: New Opportunities in the Modern Era.

Authors:  Jessica A Wilcox; Min Jun Li; Adrienne A Boire
Journal:  Neurotherapeutics       Date:  2022-07-05       Impact factor: 7.620

2.  Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment.

Authors:  Ticiana Leal; Julie E Chang; Minesh Mehta; H Ian Robins
Journal:  Curr Cancer Ther Rev       Date:  2011-11

3.  Complete response and long-term survival of leptomeningeal carcinomatosis from breast cancer with maintenance endocrine therapy.

Authors:  Muneera Majed Almajed; Khashayar Esfahani; Manuela Pelmus; Lawrence Panasci
Journal:  BMJ Case Rep       Date:  2016-06-02

Review 4.  Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.

Authors:  R Costa; B A Carneiro; D A Wainwright; C A Santa-Maria; P Kumthekar; Y K Chae; W J Gradishar; M Cristofanilli; F J Giles
Journal:  Ann Oncol       Date:  2017-01-01       Impact factor: 51.769

5.  Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review.

Authors:  Leonor Fernandes; Leonor Vasconcelos de Matos; Débora Cardoso; Marlene Saraiva; Renata Medeiros-Mirra; Andreia Coelho; Helena Miranda; Ana Martins
Journal:  CNS Oncol       Date:  2020-10-20

Review 6.  Treatment strategies for breast cancer brain metastases.

Authors:  Caroline Bailleux; Lauriane Eberst; Thomas Bachelot
Journal:  Br J Cancer       Date:  2020-11-30       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.